Skip to main content
Clinical Trials/CTRI/2008/091/000024
CTRI/2008/091/000024
Recruiting
Phase 3

RANDOMISED CLINICAL TRIAL TO STUDY THE EFFICACY AND TOLERABILITY OF 3- AND 4-MONTH REGIMENS CONTAINING MOXIFLOXACIN IN THE TREATMENT OF PATIENTS WITH SPUTUM SMEAR AND CULTURE POSITIVE PULMONARY TUBERCULOSIS

Indian Council of Medical Research0 sites1,650 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Health Condition 1: null- Pulmonary Tuberculosis
Sponsor
Indian Council of Medical Research
Enrollment
1650
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • a. Age 18 years to 60 years
  • b. Residing in or around Chennai or Madurai
  • c. No previous anti\-TB treatment
  • d. At least two sputum smears should be positive for tubercle bacilli by fluorescent microscopy at enrollment
  • e. Willing to attend the treatment centre for supervised treatment
  • f. Willing for home visits by the staff of the center.
  • g. Willing to give written informed consent.

Exclusion Criteria

  • a. Body weight less than 30 kg
  • b. Hepatic or renal disease as evidenced by clinical or biochemical abnormalities
  • c. Diabetes mellitus
  • d. History of seizure or loss of consciousness
  • e. Psychiatric illness
  • f. Abnormal electrocardiogram or anti\-arrhythmic medication
  • g. Those in a moribund state
  • h. Sero\-positive for HIV antibodies
  • i. Pregnancy or lactation
  • j. Visual disorders other than refractory error

Outcomes

Primary Outcomes

Not specified

Similar Trials